JP7804631B2 - コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用 - Google Patents
コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用Info
- Publication number
- JP7804631B2 JP7804631B2 JP2023196356A JP2023196356A JP7804631B2 JP 7804631 B2 JP7804631 B2 JP 7804631B2 JP 2023196356 A JP2023196356 A JP 2023196356A JP 2023196356 A JP2023196356 A JP 2023196356A JP 7804631 B2 JP7804631 B2 JP 7804631B2
- Authority
- JP
- Japan
- Prior art keywords
- kda
- polysaccharide
- serotype
- average molecular
- molecular weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022186098 | 2022-11-22 | ||
| JP2022186098 | 2022-11-22 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024075506A JP2024075506A (ja) | 2024-06-03 |
| JP2024075506A5 JP2024075506A5 (cg-RX-API-DMAC7.html) | 2025-07-30 |
| JP7804631B2 true JP7804631B2 (ja) | 2026-01-22 |
Family
ID=91321582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023196356A Active JP7804631B2 (ja) | 2022-11-22 | 2023-11-20 | コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7804631B2 (cg-RX-API-DMAC7.html) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014111344A1 (en) | 2013-01-15 | 2014-07-24 | Novartis Ag | Cycloalkyne derivatized saccharides |
| CN107261130A (zh) | 2017-06-29 | 2017-10-20 | 云南沃森生物技术股份有限公司 | 一种用dsc作为活化剂的细菌多糖蛋白结合疫苗的制备方法 |
| WO2017220753A1 (en) | 2016-06-22 | 2017-12-28 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Pneumococcal polysaccharide-protein conjugate composition |
| JP2019526573A (ja) | 2016-09-02 | 2019-09-19 | サノフィ パスツール インコーポレイテッド | ナイセリア・メニンギティディスのワクチン |
| JP2020504760A (ja) | 2016-12-30 | 2020-02-13 | ストロバックス・インコーポレイテッドSutrovax, Inc. | 非天然アミノ酸とのポリペプチド抗原接合体 |
| US20200054739A1 (en) | 2016-12-30 | 2020-02-20 | Sutrovax, Inc. | Conjugated vaccines |
| JP2024522395A (ja) | 2021-05-28 | 2024-06-19 | ファイザー・インク | コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用 |
| WO2025133971A1 (en) | 2023-12-23 | 2025-06-26 | Pfizer Inc. | Improved methods for producing bacterial capsular saccharide glycoconjugates |
-
2023
- 2023-11-20 JP JP2023196356A patent/JP7804631B2/ja active Active
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014111344A1 (en) | 2013-01-15 | 2014-07-24 | Novartis Ag | Cycloalkyne derivatized saccharides |
| WO2017220753A1 (en) | 2016-06-22 | 2017-12-28 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Pneumococcal polysaccharide-protein conjugate composition |
| JP2019526573A (ja) | 2016-09-02 | 2019-09-19 | サノフィ パスツール インコーポレイテッド | ナイセリア・メニンギティディスのワクチン |
| JP2020504760A (ja) | 2016-12-30 | 2020-02-13 | ストロバックス・インコーポレイテッドSutrovax, Inc. | 非天然アミノ酸とのポリペプチド抗原接合体 |
| US20200054739A1 (en) | 2016-12-30 | 2020-02-20 | Sutrovax, Inc. | Conjugated vaccines |
| CN107261130A (zh) | 2017-06-29 | 2017-10-20 | 云南沃森生物技术股份有限公司 | 一种用dsc作为活化剂的细菌多糖蛋白结合疫苗的制备方法 |
| JP2024522395A (ja) | 2021-05-28 | 2024-06-19 | ファイザー・インク | コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用 |
| WO2025133971A1 (en) | 2023-12-23 | 2025-06-26 | Pfizer Inc. | Improved methods for producing bacterial capsular saccharide glycoconjugates |
Non-Patent Citations (3)
| Title |
|---|
| CHEN, Yu-Qiu, et al.,Preparing Polysaccharide-Protein Conjugates by Using N,N'-Carbonyldiimidazole as the Activator of Capsule Polysaccharide of Group A Meningococcal,Chinese Journal of Pharmaceutical Biotechnology,2018年,Vol.25, No.1,pp.26-30,DOI 10.19526/j.cnki.1005-8915.20180106 |
| Glycoconjugate Journal,2020年,Vol.37,p.611-622 |
| Vaccine,2013年,Vol.31,p.5623-5626 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024075506A (ja) | 2024-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7714690B2 (ja) | コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用 | |
| JP7585203B2 (ja) | 免疫原性多重ヘテロ抗原多糖-タンパク質コンジュゲートおよびその使用 | |
| JP6884145B2 (ja) | 肺炎連鎖球菌ワクチンにおいて用いるための免疫原性組成物 | |
| KR20170102009A (ko) | 폐렴구균 백신에서 사용하기 위한 면역원성 조성물 | |
| US20220387576A1 (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | |
| US20250381259A1 (en) | Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof | |
| WO2025133971A1 (en) | Improved methods for producing bacterial capsular saccharide glycoconjugates | |
| CA3252845A1 (en) | PROCESS FOR PRODUCING FERTILIZER FROM A BIOGAS FLOW | |
| RU2837543C2 (ru) | Иммуногенные композиции, содержащие конъюгированные капсульные сахаридные антигены, и их применение | |
| RU2854787C2 (ru) | Иммуногенные композиции, содержащие конъюгированные капсульные сахаридные антигены, и их применение | |
| JP2024075506A (ja) | コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用 | |
| KR20240087549A (ko) | 접합된 피막 사카라이드 항원을 포함하는 면역원성 조성물 및 그의 용도 | |
| KR20240086722A (ko) | 접합된 피막 사카라이드 항원을 포함하는 면역원성 조성물 및 그의 용도 | |
| HK40104691A (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | |
| CN117729933A (zh) | 包含缀合的荚膜糖抗原的免疫原性组合物及其用途 | |
| EP4661911A1 (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | |
| WO2025186705A2 (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | |
| JP2025537898A (ja) | コンジュゲートさせた莢膜糖類抗原を含む免疫原性組成物およびその使用 | |
| HK40112911A (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250722 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250722 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20250722 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20251027 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251027 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20260105 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20260109 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7804631 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |